Lipid Efficacy Study (0524B-022)(COMPLETED)

Clinical trial NCT00269217 · COMPLETED

Trial details

NCT number: NCT00269217
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Hypercholesterolemia Mixed Hyperlipidemia

Start date: 2006-01-01
Primary completion: 2007-01-01
Enrollment: 1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.